DIALYSIS · CCN 192738

DaVita Earhart Dialysis

NEW ORLEANS, LA 70125

DialysisProfitDaVita
$3.6M
TOTAL REVENUE
15.6%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.6M
Total costs
$3.0M
Operating income (rev − costs)
$557K
Operating margin
15.6%
Total charges
$3.7M
Total treatments
10,092
Dialysis stations
15

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.9225—
Fistula Rate
DFC_FISTULA_RATE
65.572—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.232—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
3——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
138.981—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1772—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
18.4240—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
19.574—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
15.279—
Standardized ED Visits Ratio
DFC_SEDR
1.1725—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
24.122—